JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 16 No. 6 474-477
© 1975 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Persson, B. R. R.
Right arrow Articles by Kempi, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Persson, B. R. R.
Right arrow Articles by Kempi, V.

Labeling and Testing of 99mTc-Streptokinase for the Diagnosis of Deep Vein Thrombosis

Bertil R. R. Persson and Viktor Kempi

University of Lund and Centrallasarettet, Östersund, Sweden

Correspondence: For reprints contact: Bertil R. R. Persson, Dept. of Radiation Physics, Lasarettet, S-221 85 Lund, Sweden.

ABSTRACT

A detailed study has been made of the method for labeling streptokinase with 99mTc in order to get a radioactive indicator for rapid scintigraphic visualization of thrombi and emboli. The best method found for preparing 99mTc-streptokinase was by reducing 99mTc-pertechnetate with 2 µmole SnCl2 at pH 0.7 and then adding 50,000–75,000 IU of streptokinase at a final pH of about 2. After 1 hr of equilibration the labeling efficiency was 75–80% as determined by the method of gel chromatography column scanning. The dynamic behavior and distribution of 99mTc-streptokinase in different organs was studied in rabbits where a high uptake was found in liver. In a clinical investigation using 99mTc-streptokinase prepared according to this work, however, the liver uptake in man was only 10–20%.




This article has been cited by other articles:


Home page
CirculationHome page
V. H. D. Bruyn, S. R. Bergmann, B. A. Keyt, and B. E. Sobel
Visualization of Thrombi in Pulmonary Arteries With Radiolabeled, Enzymatically Inactivated Tissue-Type Plasminogen Activator
Circulation, September 1, 1995; 92(5): 1320 - 1325.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1975 by the Society of Nuclear Medicine.